Gene signature tags immunotherapy responses; National Multiple Sclerosis Society collaboration to find biomarkers;

> An immune gene signature found in a wide range of solid tumors could predict which melanoma patients will have the best survival and which might be the most likely to respond to immunotherapy. Press release

> Ezose Sciences has hooked up with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to discover new biomarkers for MS diagnosis. Press release (pdf)

> Three genes drive a hard-to-treat and aggressive form of cancer of the lining of the womb (endometrial cancer). Press release | Abstract

> Eye movements may be a sensitive biomarker for the diagnosis of schizophrenia. Press release | Abstract

> Drops in testosterone after radiation therapy for prostate cancer are linked with increased risk of cancer recurrence. Press release

> Agenix is discussing the acquisition of a Tyrian Diagnostics biomarker that has potential to distinguish patients with active TB infection from those that have been infected in the past, or have been vaccinated. Press release

> Single letter changes in the code of three genes predict which men with prostate cancer will get fatigue after androgen deprivation therapy. Abstract | Press release

> Canadian researchers have found a genetic marker that links smoking and ADHD. Article

> U.K. research shows that different genes could affect responses to TB drugs. Press release

> In multiple sclerosis, 30% of the risk of developing the disease is down to 475,806 genetic variants! Abstract | Press release

> CML HealthCare has launched a colorectal cancer blood test, COLOGIC, in Canada. Article

> Combining digital scans of images of tumor samples and genetic analysis could predict how breast cancer will progress. Press release

> One of the benefits coming out of the large Prostate Lung Colorectal and Ovarian Cancer Screening Trial (PLCO) is a risk prediction model that could pick out those people who have quit but are at risk of relapsing, or who are likely to continue smoking and not even try to quit, according to a study published in the Journal of the National Cancer Institute. Press release | Abstract

And Finally… Electronic nose sniffs breath biomarkers to diagnose obstructive sleep apnea. Press release

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.